Interscience Revenue and Competitors
Employee Data
- Interscience has 78 Employees.
- Interscience grew their employee count by 7% last year.
Interscience's People
Name | Title | Email/Phone |
---|---|---|
1 | Aplicatie engineer | Reveal Email/Phone |
Interscience Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $15M | 42 | -25% | N/A | N/A |
#2 | $300M | 5462 | 2% | N/A | N/A |
#3 | $7.5M | 26 | 18% | N/A | N/A |
#4 | N/A | 78 | 7% | N/A | N/A |
#5 | N/A | 7 | 17% | N/A | N/A |
#6 | $1.7M | 11 | 0% | N/A | N/A |
#7 | $3.5M | 33 | 0% | N/A | N/A |
#8 | $7.5M | 1 | -50% | N/A | N/A |
#9 | $15M | 82 | -16% | N/A | N/A |
What Is Interscience?
Interscience is founded in 1975 and now holds a leading market position in the field of Chromatography in the Benelux countries. It is privately owned, ISO9001 accredited, and currently employs over 65 employees, based in offices in the Netherlands and Belgium. Throughout the past 40 years we have developed expert knowledge in the areas of: + gaschromatography + mass spectrometry + multi-dimensional chromatography, GCxGC + sample preparation + sample introduction + data-handling The areas we service are: - petrochemical - environmental - hospital & health care - food & beverages - industrial - college's and universities
keywords:N/AN/A
Total Funding
78
Number of Employees
N/A
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Interscience News
INTERSCIENCE; IUL; UVP; BioMerieux; Schuett; AID; Synbiosis; BioLogics; Biocompare; WTW; Bibby Scientific; SK-Electronics. The following product...
INTERSCIENCE; Bibby Scientific; IUL; S.A.; AID; BioMerieux; UVP; BioLogics; Schuett; WTW; Synbiosis; Shineso; Wseen; ORIENTOP; SK-...
... Growth Outlook, Development Trends, Demand Opportunities, and Regional Forecast by 2028 |INTERSCIENCE, IUL, UVP, AID, BioMerieux.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $21.6M | 80 | 10% | N/A |
#2 | $21.5M | 81 | -19% | N/A |
#3 | $10.8M | 90 | 6% | N/A |
#4 | $18.7M | 91 | 8% | N/A |
#5 | $25.7M | 95 | 51% | N/A |